出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年4月
Patient Monitoring Devices Market – Global Forecast to 2029
患者監視装置市場 : 製品（心臓モニタリング装置、パルスオキシメーター、スパイロメーター、胎児モニター、体温モニター、血圧モニター、ECG、ICP、体重モニタリング）、ユーザー、顧客のアンメットニーズ – 2029年までの世界予測
Patient Monitoring Devices Market by Product (Cardiac monitoring devices, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, blood pressure monitors, ECG, ICP, weight Monitoring), User, Customer Unmet Needs- Global Forecast to 2029
| ページ数 | 409 |
| 図表数 | 457 |
| 価格 | |
| シングルユーザライセンス | USD 4,950 |
| マルチユーザライセンス（5名） | USD 6,650 |
| コーポレートライセンス | USD 8,150 |
| エンタープライズサイトライセンス | USD 10,000 |
| 種別 | 英文調査報告書 |
Report Overview
The global patient monitoring devices market is projected to reach USD 71.1 billion by 2029 from USD 48.5 billion in 2024, growing at a CAGR of 8.0% during the forecast period.
世界の患者監視装置市場は、2024年の485億米ドルから2029年までに711億米ドルに達すると予測されており、予測期間中に8.0%のCAGRで成長します。
The projected market growth for patient monitoring is supported by the convergence of benefits. Patient monitoring are driven by an aging population, increasing use of wireless monitoring devices, biosensors, and an increasing number of hospitals & clinics with more advanced monitoring devices. Furthermore, Government initiatives promoting telehealth and remote patient monitoring (RPM) through reimbursement programs can act as a catalyst for market expansion. These factors play a central role in improving healthcare delivery and patient outcomes in the coming forecasting years.
“Blood glucose monitoring systems segment to register largest market share in 2023-2029.”
Based on the product, the patient monitoring devices market is segmented into Blood glucose monitoring systems, Cardiac monitoring Devices (ECG Devices, Implantable loop recorders, Event monitors, MCT Monitors, Smart/Wearable ECG Monitors), Multi-Parameter Monitoring, Respiratory Monitoring Devices, Hemodynamic/ Pressure Monitoring Devices, Weight Monitoring Devices, Fetal & Neonatal Monitoring Devices, Neuromonitoring Devices, Temperature Monitoring Devices and others are used in patient monitoring considered for the overall market estimation. The blood glucose monitoring systems segment registered the largest market share over the forecast period of 2024-2029. The growth of this segment is due to the Rising Prevalence of Diabetes, for achieving optimal diabetes management and mitigating long-term complications hinge on early detection, continuous monitoring, and strict glycemic control. The integration of AI functionalities in certain BGMS offers the potential to generate personalized, data-driven insights for patients, empowering them to make more informed self-management decisions. Moreover, evolving Supportive policies for diabetes management and reimbursement programs for BGMS can increase patient access to these technologies.
“Hospitals & Clinics segment held the largest share of patient monitoring market in 2023, by End-user.”
Based on the end-user, the patient monitoring devices market is segmented into Hospitals & clinics, Ambulatory surgical centers and home care settings. In 2023, the hospitals & clinics segment accounted for the largest share of the global patient monitoring market. The growth of hospital & clinic segment is being propelled by factors including Rising Prevalence of Chronic Diseases, advanced patient monitors for earlier identification of potential complications, continuous advanced monitoring technologies, and integration with electronic health records (EHR) for better data management and analysis.
“Asia Pacific to register significant growth rate in the market during the forecast period.”
For the forecasting period 2024-2029, the APAC region is expected to register a significant growth rate during the forecast period. Asia Pacific comprises India, China, Japan, South Korea, Australia, and RoAPAC. The Asia-Pacific (APAC) region has witnessed a significant increase in the market growth rate for patient monitoring. There are several drivers that contributed to the growth:
The Asia Pacific market is experiencing growth due to expansion of telehealth services & remote monitoring capabilities. Additionally, the market is benefiting from the rise in home care settings, rising geriatric population is more susceptible to age-related conditions, requiring closer monitoring and management to expand their offerings of monitoring products in the Asia Pacific region.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%
• By Designation: C-level– 27%, Director-level–18%, and Others–55%
• By Region: North America–50%, Europe-20%, Asia Pacific–15%, Latin America–10%, and the Middle East & Africa–5%
Prominent players in this market are Medtronic (Ireland), GE Healthcare (US), Abbott Laboratories (US), Nihon Kohden Corporation (Japan), Philips healthcare (Netherland) among others.
Research Coverage
• The report studies the patient monitoring market based on products, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro markets with respect to their growth trends, prospects, and contributions to the global patient monitoring market.
• The report forecasts the revenue of market segments with respect to five major regions.
Key Benefits of Buying the Report:
The report will help the new entrants/ market leaders/smaller firms in this market with investment evaluation viability within the patient monitoring market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, challenges, growth catalysts and prospects, thereby empowering strategic decision-making with astute discernment.
The report provides insights on the following pointers:
• Analysis of key drivers (rising prevalence of chronic disorder diseases, aging population, Increased Focus on Early Detection and Intervention), restraints (high cost of monitoring systems, Resource-constrained settings in developing countries), opportunities (advancements in manufacturing and miniaturization of components can potentially lead to more affordable patient monitoring solutions, growth of medical tourism), and challenges (unskilled professionals) influencing the growth of the patient monitoring market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the patient monitoring market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the patient monitoring market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the patient monitoring market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Medtronic (Ireland), GE Healthcare (US), Abbott Laboratories (US), Nihon Kohden Corporation (Japan), among others.
Table of Contents
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS & EXCLUSIONS 35
1.3 MARKET SCOPE 36
1.3.1 MARKETS COVERED 36
1.3.2 REGIONS COVERED 37
1.4 YEARS CONSIDERED 37
1.5 CURRENCY CONSIDERED 37
1.6 RESEARCH LIMITATIONS 38
1.7 MARKET STAKEHOLDERS 38
1.8 SUMMARY OF CHANGES 38
1.9 RECESSION IMPACT 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
2.2 RESEARCH DESIGN 41
2.2.1 SECONDARY RESEARCH 41
FIGURE 1 KEY DATA FROM SECONDARY SOURCES 43
2.2.2 PRIMARY RESEARCH 43
2.2.2.1 Primary sources 44
2.2.2.2 Key industry insights 45
2.2.2.3 Breakdown of primaries 45
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 45
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 46
2.3 MARKET SIZE ESTIMATION 46
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 47
2.3.1 BOTTOM-UP APPROACH 47
2.3.1.1 Approach 1: Company revenue estimation approach 48
FIGURE 5 PATIENT MONITORING MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION) 48
2.3.1.2 Approach 2: Customer-based market estimation 49
FIGURE 6 PATIENT MONITORING MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 49
2.3.2 TOP-DOWN APPROACH 49
FIGURE 7 PATIENT MONITORING MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 50
2.3.3 PRIMARY INTERVIEWS 52
2.4 DATA TRIANGULATION & MARKET BREAKDOWN 52
FIGURE 8 DATA TRIANGULATION METHODOLOGY 52
2.5 MARKET SHARE ASSESSMENT 53
2.6 STUDY ASSUMPTIONS 53
2.7 MARKET FORECASTING METHODOLOGY 54
FIGURE 9 GROWTH PROJECTIONS WERE BASED ON REVENUE IMPACT OF KEY MACROINDICATORS 54
2.8 RISK ASSESSMENT 55
TABLE 1 LIMITATIONS AND ASSOCIATED RISKS 55
2.9 GROWTH RATE ASSUMPTIONS 56
2.10 RECESSION IMPACT ON PATIENT MONITORING MARKET 56
3 EXECUTIVE SUMMARY 57
FIGURE 10 PATIENT MONITORING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 57
FIGURE 11 PATIENT MONITORING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 58
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF PATIENT MONITORING MARKET 59
4 PREMIUM INSIGHTS 60
4.1 PATIENT MONITORING MARKET OVERVIEW 60
FIGURE 13 GROWING ADOPTION OF WIRELESS MONITORING DEVICES TO DRIVE MARKET GROWTH 60
4.2 PATIENT MONITORING MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 61
FIGURE 14 ASIA PACIFIC MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 61
4.3 PATIENT MONITORING MARKET, BY REGION AND END USER, 2023 (USD MILLION) 62
FIGURE 15 HOSPITALS & CLINICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 62
4.4 GEOGRAPHIC SNAPSHOT OF PATIENT MONITORING MARKET 63
FIGURE 16 JAPAN TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
FIGURE 17 PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
5.2.1 DRIVERS 65
5.2.1.1 Emergence of predictive analytics in vital sign monitors 65
5.2.1.2 Growing preference for wearable patient monitoring devices, biosensors, and smart implants 66
5.2.1.3 Availability of wireless monitoring devices 66
5.2.1.4 Expansion of telehealth services and remote monitoring capabilities 67
5.2.1.5 Growing incidence of chronic diseases 67
5.2.2 RESTRAINTS 69
5.2.2.1 Risks associated with invasive monitoring devices 69
5.2.2.2 High cost of patient monitoring products and inadequate reimbursement 70
5.2.3 OPPORTUNITIES 70
5.2.3.1 Integration with electronic health records (EHRs) 70
5.2.3.2 Expansion of remote patient monitoring in home healthcare settings 71
5.2.4 CHALLENGES 71
5.2.4.1 Lack of personnel and limited awareness & education for patient monitoring devices 71
5.2.4.2 Increased pricing pressure on market players 72
5.3 PORTER’S FIVE FORCES ANALYSIS 73
TABLE 2 PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS 73
5.3.1 THREAT OF NEW ENTRANTS 73
5.3.2 THREAT OF SUBSTITUTES 73
5.3.3 BARGAINING POWER OF SUPPLIERS 74
5.3.4 BARGAINING POWER OF BUYERS 74
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 74
5.4 REGULATORY ANALYSIS 74
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 6 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 7 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
5.5 KEY REGULATORY GUIDELINES 78
5.5.1 NORTH AMERICA 78
5.5.1.1 US 78
TABLE 8 US: CLASSIFICATION OF MEDICAL EQUIPMENT 78
TABLE 9 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 78
5.5.1.2 Canada 79
TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 79
5.5.2 EUROPE 79
TABLE 11 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 80
5.5.3 ASIA PACIFIC 80
5.5.3.1 Japan 80
TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 81
5.5.3.2 India 81
5.5.3.3 China 81
5.6 REIMBURSEMENT SCENARIO 82
TABLE 13 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES 82
5.7 ECOSYSTEM ANALYSIS 84
5.8 KEY MARKET PLAYERS IN PATIENT MONITORING MARKET 85
5.9 INVESTMENT & FUNDING SCENARIO 85
FIGURE 18 NUMBER OF INVESTOR DEALS IN PATIENT MONITORING MARKET, BY KEY PLAYER, 2018–2022 85
FIGURE 19 VALUE OF INVESTOR DEALS IN PATIENT MONITORING MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION) 86
5.10 TECHNOLOGY ANALYSIS 86
5.10.1 KEY TECHNOLOGIES 86
5.10.1.1 Smart wearable monitoring devices 86
5.10.1.2 Vital sign monitors 87
5.10.2 COMPLEMENTARY TECHNOLOGIES 87
5.10.2.1 Remote patient monitors 87
5.10.2.2 AI & IoT 87
5.10.2.3 Telehealth 88
5.10.3 ADJACENT TECHNOLOGIES 88
5.10.3.1 IVD 88
5.10.3.2 Medical imaging 88
5.11 VALUE CHAIN ANALYSIS 89
5.11.1 RESEARCH & DEVELOPMENT 89
5.11.2 PROCUREMENT AND PRODUCT DEVELOPMENT 89
5.11.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES 89
FIGURE 20 PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS 90
5.12 SUPPLY CHAIN ANALYSIS 90
5.12.1 PROMINENT COMPANIES 90
5.12.2 SMALL & MEDIUM-SIZED COMPANIES 90
5.12.3 END USERS 90
FIGURE 21 PATIENT MONITORING MARKET: SUPPLY CHAIN ANALYSIS 91
5.13 PRICING ANALYSIS 91
FIGURE 22 AVERAGE SELLING PRICE OF PATIENT MONITORING DEVICES, BY PRODUCT (FY 2021–2023) 91
FIGURE 23 AVERAGE SELLING PRICE TREND OF PATIENT MONITORING DEVICES, BY REGION, 2021–2023 (USD) 92
5.14 PATENT ANALYSIS 93
FIGURE 24 PATENT DETAILS FOR PATIENT MONITORING DEVICES (JANUARY 2013–DECEMBER 2023) 93
5.15 TRADE ANALYSIS 93
TABLE 14 IMPORT DATA FOR PATIENT MONITORING DEVICES (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND) 93
TABLE 15 EXPORT DATA FOR PATIENT MONITORING DEVICES (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND) 94
5.16 KEY CONFERENCES & EVENTS, 2024–2025 94
TABLE 16 PATIENT MONITORING MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS IN 2024–2025 94
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 96
FIGURE 25 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 96
5.18 KEY STAKEHOLDERS & BUYING CRITERIA 96
5.18.1 KEY STAKEHOLDERS IN BUYING PROCESS 96
TABLE 17 KEY REQUIREMENTS OF DEPARTMENTS/STAKEHOLDERS WHILE BUYING PATIENT MONITORING DEVICES 96
5.18.2 BUYING CRITERIA 97
FIGURE 26 BUYING CRITERIA 97
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PATIENT MONITORING DEVICES 97
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%) 98
5.19 PATIENT MONITORING MARKET: RECESSION IMPACT 98
5.20 UNMET NEEDS & KEY PAIN POINTS 99
TABLE 19 PATIENT MONITORING MARKET: UNMET CUSTOMER NEEDS & KEY PAIN POINTS 99
6 PATIENT MONITORING MARKET, BY PRODUCT 100
6.1 INTRODUCTION 101
TABLE 20 PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 101
6.2 BLOOD GLUCOSE MONITORING DEVICES 102
TABLE 21 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 102
TABLE 22 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 102
TABLE 23 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 103
6.2.1 SELF-MONITORING BLOOD GLUCOSE DEVICES 103
6.2.1.1 Rising adoption of integrated glucose monitoring devices to drive growth 103
TABLE 24 SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 104
6.2.2 CONTINUOUS GLUCOSE MONITORING DEVICES 105
6.2.2.1 Product launches and evolving reimbursement scenarios for continuous monitoring devices to drive market growth 105
TABLE 25 CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 106
6.2.3 WEARABLE GLUCOSE MONITORING DEVICES 106
6.2.3.1 Growing patient inclination towards wearable monitors to boost market 106
TABLE 26 WEARABLE GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 106
6.3 CARDIAC MONITORING DEVICES 107
TABLE 27 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 107
TABLE 28 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 107
TABLE 29 CARDIAC MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 108
6.3.1 ECG DEVICES 108
6.3.1.1 Low cost and wide applications of ECG devices to drive market growth 108
TABLE 30 ECG DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 109
6.3.2 IMPLANTABLE LOOP RECORDERS (ILRS) 109
6.3.2.1 High cost and limited applications to limit growth 109
TABLE 31 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2022–2029 (USD MILLION) 110
6.3.3 EVENT MONITORS 110
6.3.3.1 Emergence of portable and wireless event monitors to drive market growth 110
TABLE 32 EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 111
6.3.4 MCT MONITORS 112
6.3.4.1 Availability of alternate technologies to hinder market growth 112
TABLE 33 MCT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 112
6.3.5 SMART/WEARABLE ECG MONITORS 113
6.3.5.1 Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors 113
TABLE 34 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS 113
TABLE 35 SMART/WEARABLE ECG MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 114
6.4 MULTIPARAMETER MONITORING DEVICES 115
TABLE 36 MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 115
TABLE 37 MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 115
TABLE 38 MULTIPARAMETER MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 116
6.4.1 LOW-ACUITY MONITORS 116
6.4.1.1 Increasing adoption of low-acuity monitors in general wards to drive market growth 116
TABLE 39 LOW-ACUITY MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 116
6.4.2 MID-ACUITY MONITORS 117
6.4.2.1 Rising geriatric population to increase market growth 117
TABLE 40 MID-ACUITY MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 117
6.4.3 HIGH-ACUITY MONITORS 117
6.4.3.1 Increasing partnerships between manufacturers and hospitals & clinics to drive device sales 117
TABLE 41 HIGH-ACUITY MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 118
6.5 RESPIRATORY MONITORING DEVICES 118
TABLE 42 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 118
TABLE 43 RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 119
TABLE 44 RESPIRATORY MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 119
6.5.1 PULSE OXIMETERS 120
6.5.1.1 Rising adoption of pulse oximeters in home care settings to drive market growth 120
TABLE 45 PULSE OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 120
6.5.2 SPIROMETERS 121
6.5.2.1 Technological advancements to increase adoption of spirometers 121
TABLE 46 SPIROMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 122
6.5.3 CAPNOGRAPHS 122
6.5.3.1 Product development and growing commercial acceptance to drive market growth 122
TABLE 47 CAPNOGRAPHS MARKET, BY REGION, 2022–2029 (USD MILLION) 123
6.5.4 PEAK FLOW METERS 123
6.5.4.1 Low preference for peak flow meters due to high variability in measurements from different devices to hinder market growth 123
TABLE 48 PEAK FLOW METERS MARKET, BY REGION, 2022–2029 (USD MILLION) 124
6.6 TEMPERATURE MONITORING DEVICES 124
TABLE 49 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 124
TABLE 50 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 125
TABLE 51 TEMPERATURE MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 125
6.6.1 HANDHELD TEMPERATURE MONITORING DEVICES 126
6.6.1.1 Advantages associated with handheld temperature monitoring devices to drive market growth 126
TABLE 52 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS 127
TABLE 53 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 127
6.6.2 TABLE-TOP TEMPERATURE MONITORING DEVICES 128
6.6.2.1 Increasing risks associated with hypothermia during surgeries to drive demand for table-top devices 128
TABLE 54 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 128
6.6.3 WEARABLE CONTINUOUS MONITORING DEVICES 129
6.6.3.1 Versatile functionalities offered by wearable continuous monitoring devices to drive demand 129
TABLE 55 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS 129
TABLE 56 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 130
6.6.4 INVASIVE TEMPERATURE MONITORING DEVICES 130
6.6.4.1 Risk of bloodstream infections associated with catheter usage to hinder market for invasive devices 130
TABLE 57 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 131
6.6.5 SMART TEMPERATURE MONITORING PATCHES 131
6.6.5.1 Long-term monitoring capabilities of smart patches to drive market growth 131
TABLE 58 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS 132
TABLE 59 SMART TEMPERATURE MONITORING PATCHES MARKET, BY REGION, 2022–2029 (USD MILLION) 132
6.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES 133
TABLE 60 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 133
TABLE 61 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 133
TABLE 62 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 134
6.7.1 HEMODYNAMIC MONITORS 134
6.7.1.1 Influx of VC funding to drive market growth 134
TABLE 63 HEMODYNAMIC MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 135
6.7.2 BLOOD PRESSURE MONITORS 135
6.7.2.1 Development of wearable blood pressure monitors to drive market growth 135
TABLE 64 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS 136
TABLE 65 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 136
6.7.3 DISPOSABLES 137
6.7.3.1 Growing number of surgical procedures to drive growth in disposables market 137
TABLE 66 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 137
6.8 FETAL & NEONATAL MONITORING DEVICES 137
TABLE 67 FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 138
TABLE 68 FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 138
TABLE 69 FETAL & NEONATAL MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 139
6.8.1 FETAL MONITORING DEVICES 139
6.8.1.1 Rising prevalence of obstetric complications to drive market growth 139
TABLE 70 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS 141
TABLE 71 FETAL MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 141
6.8.2 NEONATAL MONITORING DEVICES 142
6.8.2.1 Rising number of neonatal care facilities worldwide to drive market 142
TABLE 72 NEONATAL MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 142
6.9 NEUROMONITORING DEVICES 142
TABLE 73 NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 143
TABLE 74 NEUROMONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 143
TABLE 75 NEUROMONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 144
6.9.1 EEG MACHINES 144
6.9.1.1 Growing applications and technological advancements to favor market growth 144
TABLE 76 EEG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 145
6.9.2 EMG MACHINES 145
6.9.2.1 Availability of reimbursements for EMG-assisted surgeries to boost product demand 145
TABLE 77 EMG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 146
6.9.3 CEREBRAL OXIMETERS 146
6.9.3.1 Growing cases of hypoxia during surgical procedures to drive market growth 146
TABLE 78 CEREBRAL OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 147
6.9.4 ICP MONITORS 147
6.9.4.1 Growing incidence of post-surgical cerebrovascular complications and TBIs to support adoption of ICP monitors 147
TABLE 79 ICP MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION) 148
6.9.5 MEG MACHINES 148
6.9.5.1 High implementation and maintenance costs of MEG devices to hinder market growth 148
TABLE 80 MEG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 149
6.9.6 TCD MACHINES 149
6.9.6.1 Rising prevalence of strokes and cerebrovascular disorders to contribute to market growth 149
TABLE 81 TCD MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION) 150
6.10 WEIGHT MONITORING DEVICES 150
TABLE 82 WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 150
TABLE 83 WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 151
TABLE 84 WEIGHT MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 151
6.10.1 DIGITAL WEIGHT MONITORING DEVICES 151
6.10.1.1 Consumer preference for digital scales—a key market driver 151
TABLE 85 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 152
6.10.2 ANALOG WEIGHT MONITORING DEVICES 152
6.10.2.1 Rising prevalence of obesity and low cost of analog scales to support market growth 152
TABLE 86 ANALOG WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 153
6.11 OTHER PATIENT MONITORING DEVICES 153
TABLE 87 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS 153
TABLE 88 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS 154
TABLE 89 OTHER PATIENT MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 155
TABLE 90 OTHER PATIENT MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 155
7 PATIENT MONITORING MARKET, BY END USER 156
7.1 INTRODUCTION 157
TABLE 91 PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION) 157
7.2 HOSPITALS & CLINICS 157
7.2.1 ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF PATIENT MONITORING TECHNOLOGIES TO BOOST MARKET 157
TABLE 92 PATIENT MONITORING MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION) 158
TABLE 93 PATIENT MONITORING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION) 158
7.3 AMBULATORY SURGICAL CENTERS 159
7.3.1 COST-EFFECTIVENESS AND CONVENIENCE OF AMBULATORY SURGICAL CENTERS TO DRIVE DEMAND FOR AMBULATORY CARE 159
TABLE 94 PATIENT MONITORING MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022–2029 (USD MILLION) 159
7.4 HOME CARE SETTINGS 160
7.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH 160
TABLE 95 PATIENT MONITORING MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD MILLION) 160
7.5 OTHER END USERS 161
TABLE 96 PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 161
8 PATIENT MONITORING MARKET, BY REGION 162
8.1 INTRODUCTION 163
TABLE 97 PATIENT MONITORING MARKET, BY REGION, 2022–2029 (USD MILLION) 163
8.2 NORTH AMERICA 164
FIGURE 28 NORTH AMERICA: PATIENT MONITORING MARKET SNAPSHOT 164
TABLE 98 NORTH AMERICA: PATIENT MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 99 NORTH AMERICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 165
TABLE 100 NORTH AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 101 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 102 NORTH AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 167
TABLE 103 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 167
TABLE 104 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 168
TABLE 105 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 168
TABLE 106 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 107 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 108 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 170
TABLE 109 NORTH AMERICA: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION) 170
8.2.1 NORTH AMERICA: RECESSON IMPACT 170
8.2.2 US 171
8.2.2.1 Growing number of FDA approvals for patient monitoring devices to support market growth 171
TABLE 110 VC FUNDING IN PATIENT MONITORING MARKET IN US 171
TABLE 111 US: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 172
TABLE 112 US: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 172
TABLE 113 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 173
TABLE 114 US: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 173
TABLE 115 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 116 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 117 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 118 US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 119 US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 120 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 176
8.2.3 CANADA 176
8.2.3.1 Growing public-private funding for research to drive market growth 176
TABLE 121 RESEARCH GRANTS IN PATIENT MONITORING MARKET IN CANADA 177
TABLE 122 RECENT DEVELOPMENTS IN CANADIAN PATIENT MONITORING MARKET 178
TABLE 123 CANADA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 179
TABLE 124 CANADA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 125 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 180
TABLE 126 CANADA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 180
TABLE 127 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 128 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 129 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 130 CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 131 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 183
TABLE 132 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 183
8.3 EUROPE 183
TABLE 133 PRODUCT APPROVALS IN EUROPEAN PATIENT MONITORING MARKET 184
TABLE 134 EUROPE: PATIENT MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 184
TABLE 135 EUROPE: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 185
TABLE 136 EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 137 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 186
TABLE 138 EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 186
TABLE 139 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 140 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 141 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 142 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 143 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 144 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 145 EUROPE: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION) 190
8.3.1 EUROPE: RECESSION IMPACT 190
8.3.2 GERMANY 190
8.3.2.1 Rising healthcare expenditure and manufacturer expansion to boost market growth 190
TABLE 146 GERMANY: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 191
TABLE 147 GERMANY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 148 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 149 GERMANY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 150 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 193
TABLE 151 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 193
TABLE 152 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 153 GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 154 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 155 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
8.3.3 UK 196
8.3.3.1 Increasing public & private investments to contribute to market growth 196
TABLE 156 UK: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 196
TABLE 157 UK: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 158 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 159 UK: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 160 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 161 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 199
TABLE 162 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 199
TABLE 163 UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 200
TABLE 164 UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 200
TABLE 165 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 201
8.3.4 FRANCE 201
8.3.4.1 Statutory health insurance system to support market growth 201
TABLE 166 FRANCE: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 202
TABLE 167 FRANCE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 202
TABLE 168 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 169 FRANCE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 170 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 171 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 172 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 173 FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 174 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 206
TABLE 175 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 206
8.3.5 ITALY 206
8.3.5.1 Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices 206
TABLE 176 ITALY: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 207
TABLE 177 ITALY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 178 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 179 ITALY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 180 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 181 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 182 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 183 ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 184 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 185 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 212
8.3.6 SPAIN 212
8.3.6.1 Growing number of surgical procedures to drive market growth in Spain 212
TABLE 186 SPAIN: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 213
TABLE 187 SPAIN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 188 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 189 SPAIN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 190 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 191 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 192 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 193 SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 194 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 195 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 217
8.3.7 REST OF EUROPE 218
TABLE 196 KEY MERGERS & ACQUISITIONS AND PARTNERSHIPS IN PATIENT MONITORING MARKET IN ROE 218
TABLE 197 REST OF EUROPE: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 219
TABLE 198 REST OF EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 199 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 200 REST OF EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 201 REST OF EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 202 REST OF EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 203 REST OF EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 204 REST OF EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 205 REST OF EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 223
TABLE 206 REST OF EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 223
8.4 ASIA PACIFIC 224
FIGURE 29 ASIA PACIFIC: PATIENT MONITORING MARKET SNAPSHOT 225
TABLE 207 ASIA PACIFIC: PATIENT MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 226
TABLE 208 ASIA PACIFIC: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 226
TABLE 209 ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 227
TABLE 210 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 227
TABLE 211 ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 228
TABLE 212 ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 228
TABLE 213 ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 214 ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 215 ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 216 ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 217 ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 231
TABLE 218 ASIA PACIFIC: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION) 231
8.4.1 ASIA PACIFIC: RECESSION IMAPCT 231
8.4.2 JAPAN 232
8.4.2.1 Large geriatric population and favorable reimbursement scenario to support market growth 232
TABLE 219 RECENT DEVELOPMENTS IN PATIENT MONITORING MARKET IN JAPAN 232
TABLE 220 JAPAN: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 233
TABLE 221 JAPAN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 222 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 223 JAPAN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 235
TABLE 224 JAPAN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 235
TABLE 225 JAPAN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 236
TABLE 226 JAPAN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 236
TABLE 227 JAPAN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 237
TABLE 228 JAPAN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 237
TABLE 229 JAPAN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 238
8.4.3 CHINA 238
8.4.3.1 Growing focus of local and international market players to favor market growth 238
TABLE 230 RECENT DEVELOPMENTS IN PATIENT MONITORING MARKET IN CHINA 238
TABLE 231 CHINA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 239
TABLE 232 CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 240
TABLE 233 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 240
TABLE 234 CHINA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 241
TABLE 235 CHINA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 241
TABLE 236 CHINA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 237 CHINA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 238 CHINA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 243
TABLE 239 CHINA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 243
TABLE 240 CHINA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 244
8.4.4 INDIA 244
8.4.4.1 Increasing government-implemented healthcare initiatives to support market growth 244
TABLE 241 INDIA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 245
TABLE 242 INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 246
TABLE 243 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 246
TABLE 244 INDIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 247
TABLE 245 INDIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 247
TABLE 246 INDIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 248
TABLE 247 INDIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 248
TABLE 248 INDIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 249
TABLE 249 INDIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 249
TABLE 250 INDIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 250
8.4.5 AUSTRALIA 250
8.4.5.1 R&D Tax Incentive Program to support market growth 250
TABLE 251 AUSTRALIA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 251
TABLE 252 AUSTRALIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 251
TABLE 253 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 252
TABLE 254 AUSTRALIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 252
TABLE 255 AUSTRALIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 253
TABLE 256 AUSTRALIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 253
TABLE 257 AUSTRALIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 254
TABLE 258 AUSTRALIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 254
TABLE 259 AUSTRALIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 255
TABLE 260 AUSTRALIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 255
8.4.6 SOUTH KOREA 255
8.4.6.1 Supportive government initiatives to drive market growth 255
TABLE 261 SOUTH KOREA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 256
TABLE 262 SOUTH KOREA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 256
TABLE 263 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 257
TABLE 264 SOUTH KOREA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 257
TABLE 265 SOUTH KOREA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 258
TABLE 266 SOUTH KOREA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 258
TABLE 267 SOUTH KOREA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 259
TABLE 268 SOUTH KOREA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 259
TABLE 269 SOUTH KOREA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 260
TABLE 270 SOUTH KOREA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 260
8.4.7 REST OF ASIA PACIFIC 260
TABLE 271 RECENT DEVELOPMENTS IN PATIENT MONITORING MARKET IN ROAPAC 261
TABLE 272 REST OF ASIA PACIFIC: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 262
TABLE 273 REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 262
TABLE 274 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 263
TABLE 275 REST OF ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 263
TABLE 276 REST OF ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 264
TABLE 277 REST OF ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 264
TABLE 278 REST OF ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 265
TABLE 279 REST OF ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 265
TABLE 280 REST OF ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 266
TABLE 281 REST OF ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 266
8.5 LATIN AMERICA 266
TABLE 282 LATIN AMERICA: PATIENT MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 267
TABLE 283 LATIN AMERICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 267
TABLE 284 LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 268
TABLE 285 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 268
TABLE 286 LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 269
TABLE 287 LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 269
TABLE 288 LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 270
TABLE 289 LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 270
TABLE 290 LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 271
TABLE 291 LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 271
TABLE 292 LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 272
TABLE 293 LATIN AMERICA: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION) 272
8.5.1 LATIN AMERICA: RECESSION IMAPCT 272
8.5.2 BRAZIL 273
8.5.2.1 Brazil to dominate LATAM market 273
TABLE 294 BRAZIL: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 274
TABLE 295 BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 274
TABLE 296 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 275
TABLE 297 BRAZIL: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 275
TABLE 298 BRAZIL: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 276
TABLE 299 BRAZIL: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 276
TABLE 300 BRAZIL: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 277
TABLE 301 BRAZIL: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 277
TABLE 302 BRAZIL: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 278
TABLE 303 BRAZIL: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 278
8.5.3 MEXICO 278
8.5.3.1 Favorable investment scenario for medical device manufacturers to drive market growth 278
TABLE 304 MEXICO: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 279
TABLE 305 MEXICO: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 280
TABLE 306 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 280
TABLE 307 MEXICO: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 281
TABLE 308 MEXICO: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 281
TABLE 309 MEXICO: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 282
TABLE 310 MEXICO: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 282
TABLE 311 MEXICO: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 283
TABLE 312 MEXICO: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 283
TABLE 313 MEXICO: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 283
8.5.4 REST OF LATIN AMERICA 284
TABLE 314 REST OF LATIN AMERICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 285
TABLE 315 REST OF LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 285
TABLE 316 REST OF LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 286
TABLE 317 REST OF LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 286
TABLE 318 REST OF LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 287
TABLE 319 REST OF LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 287
TABLE 320 REST OF LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 288
TABLE 321 REST OF LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 288
TABLE 322 REST OF LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 289
TABLE 323 REST OF LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 289
8.6 MIDDLE EAST & AFRICA 289
8.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF PATIENT MONITORING DEVICES IN REGION 289
TABLE 324 MIDDLE EAST & AFRICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 291
TABLE 325 MIDDLE EAST & AFRICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 291
TABLE 326 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 292
TABLE 327 MIDDLE EAST & AFRICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 292
TABLE 328 MIDDLE EAST & AFRICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 293
TABLE 329 MIDDLE EAST & AFRICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 293
TABLE 330 MIDDLE EAST & AFRICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 294
TABLE 331 MIDDLE EAST & AFRICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 294
TABLE 332 MIDDLE EAST & AFRICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 295
TABLE 333 MIDDLE EAST & AFRICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 295
TABLE 334 MIDDLE EAST & AFRICA: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION) 296
8.6.2 MIDDLE EAST & AFRICA: RECESSION IMAPCT 296
9 COMPETITIVE LANDSCAPE 297
9.1 OVERVIEW 297
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 297
9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PATIENT MONITORING PLAYERS 298
9.3 REVENUE ANALYSIS 299
FIGURE 30 REVENUE ANALYSIS OF TOP PLAYERS IN PATIENT MONITORING MARKET, 2019–2023 (USD MILLION) 299
9.4 MARKET SHARE ANALYSIS 300
9.4.1 GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023 300
FIGURE 31 BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE ANALYSIS, 2023 300
9.4.2 GLOBAL CARDIAC MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023 301
FIGURE 32 CARDIAC MONITORING DEVICES MARKET SHARE ANALYSIS, 2023 301
9.4.3 GLOBAL MULTIPARAMETER MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023 301
FIGURE 33 MULTIPARAMETER MONITORING DEVICES MARKET SHARE ANALYSIS, 2023 301
9.4.4 GLOBAL HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023 302
FIGURE 34 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE ANALYSIS, 2023 302
9.4.5 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023 302
FIGURE 35 FETAL & NEONATAL MONITORING DEVICES MARKET SHARE ANALYSIS, 2023 302
TABLE 335 PATIENT MONITORING MARKET: DEGREE OF COMPETITION 303
9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 305
9.5.1 STARS 305
9.5.2 EMERGING LEADERS 305
9.5.3 PERVASIVE PLAYERS 305
9.5.4 PARTICIPANTS 305
FIGURE 36 PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 306
9.5.5 COMPANY FOOTPRINT: KEY PLAYERS 307
FIGURE 37 COMPANY FOOTPRINT (15 COMPANIES) 307
TABLE 336 PRODUCT FOOTPRINT (15 COMPANIES) 308
TABLE 337 REGIONAL FOOTPRINT (15 COMPANIES) 308
9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES 309
9.6.1 PROGRESSIVE COMPANIES 309
9.6.2 RESPONSIVE COMPANIES 309
9.6.3 DYNAMIC COMPANIES 309
9.6.4 STARTING BLOCKS 309
FIGURE 38 PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 310
9.6.5 COMPETITIVE BENCHMARKING 310
TABLE 338 PATIENT MONITORING MARKET: DETAILED LIST OF KEY EMERGING PLAYERS/STARTUPS 310
TABLE 339 PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 311
9.7 COMPETITIVE SCENARIO 312
9.7.1 PRODUCT LAUNCHES & APPROVALS 312
TABLE 340 PATIENT MONITORING MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–OCTOBER 2023 312
9.7.2 DEALS 313
TABLE 341 PATIENT MONITORING MARKET: DEALS, JANUARY 2021–FEBRUARY 2024 313
9.8 COMPANY VALUATION & FINANCIAL METRICS 314
FIGURE 39 EV/EBITDA OF KEY VENDORS 314
FIGURE 40 5-YEAR STOCK BETA OF KEY VENDORS 314
9.9 PRODUCT/BRAND COMPARISON 315
FIGURE 41 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL (2023) 315
10 COMPANY PROFILES 316
10.1 KEY PLAYERS 316
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
10.1.1 MEDTRONIC PLC 316
TABLE 342 MEDTRONIC PLC: COMPANY OVERVIEW 316
FIGURE 42 MEDTRONIC PLC: COMPANY SNAPSHOT (2023) 317
TABLE 343 MEDTRONIC PLC: PRODUCTS OFFERED 318
TABLE 344 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS 320
TABLE 345 MEDTRONIC PLC: DEALS 321
10.1.2 ABBOTT LABORATORIES 323
TABLE 346 ABBOTT LABORATORIES: COMPANY OVERVIEW 323
FIGURE 43 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022) 324
TABLE 347 ABBOTT LABORATORIES: PRODUCTS OFFERED 324
TABLE 348 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS 325
TABLE 349 ABBOTT LABORATORIES: DEALS 326
10.1.3 DEXCOM, INC. 327
TABLE 350 DEXCOM, INC.: COMPANY OVERVIEW 327
FIGURE 44 DEXCOM, INC.: COMPANY SNAPSHOT (2023) 327
TABLE 351 DEXCOM, INC.: PRODUCTS OFFERED 328
TABLE 352 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS 328
10.1.4 GE HEALTHCARE 330
TABLE 353 GE HEALTHCARE: COMPANY OVERVIEW 330
FIGURE 45 GE HEALTHCARE: COMPANY SNAPSHOT (2023) 331
TABLE 354 GE HEALTHCARE: PRODUCTS OFFERED 331
TABLE 355 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS 333
TABLE 356 GE HEALTHCARE: DEALS 333
10.1.5 PHILIPS HEALTHCARE 335
TABLE 357 PHILIPS HEALTHCARE: COMPANY OVERVIEW 335
FIGURE 46 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2023) 336
TABLE 358 PHILIPS HEALTHCARE: PRODUCTS OFFERED 336
TABLE 359 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS 338
TABLE 360 PHILIPS HEALTHCARE: DEALS 339
10.1.6 NIHON KOHDEN CORPORATION 341
TABLE 361 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 341
FIGURE 47 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023) 342
TABLE 362 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 342
TABLE 363 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS 345
10.1.7 MINDRAY MEDICAL INTERNATIONAL LTD. 346
TABLE 364 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY OVERVIEW 346
FIGURE 48 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY SNAPSHOT (2022) 347
TABLE 365 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCTS OFFERED 347
TABLE 366 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCT LAUNCHES & APPROVALS 349
TABLE 367 MINDRAY MEDICAL INTERNATIONAL LTD.: DEALS 349
10.1.8 EDWARDS LIFESCIENCES CORPORATION 350
TABLE 368 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW 350
FIGURE 49 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023) 351
TABLE 369 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED 351
10.1.9 GETINGE AB 353
TABLE 370 GETINGE AB: COMPANY OVERVIEW 353
FIGURE 50 GETINGE AB.: COMPANY SNAPSHOT (2023) 354
TABLE 371 GETINGE AB: PRODUCTS OFFERED 354
TABLE 372 GETINGE AB: PRODUCT LAUNCHES & APPROVALS 355
TABLE 373 GETINGE AB: DEALS 355
10.1.10 BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC.) 356
TABLE 374 BAXTER INTERNATIONAL: COMPANY OVERVIEW 356
FIGURE 51 BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2023) 357
TABLE 375 BAXTER INTERNATIONAL: PRODUCTS OFFERED 357
TABLE 376 BAXTER INTERNATIONAL: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS 359
TABLE 377 BAXTER INTERNATIONAL: DEALS 360
10.1.11 DRÄGERWERK AG & CO. KGAA 361
TABLE 378 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 361
FIGURE 52 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023) 362
TABLE 379 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 362
10.1.12 BOSTON SCIENTIFIC CORPORATION 365
TABLE 380 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 365
FIGURE 53 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 366
TABLE 381 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 366
TABLE 382 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS 367
TABLE 383 BOSTON SCIENTIFIC CORPORATION: DEALS 367
10.1.13 MASIMO CORPORATION 368
TABLE 384 MASIMO CORPORATION: COMPANY OVERVIEW 368
FIGURE 54 MASIMO CORPORATION: COMPANY SNAPSHOT (2023) 369
TABLE 385 MASIMO CORPORATION: PRODUCTS OFFERED 369
TABLE 386 MASIMO CORPORATION: PRODUCT LAUNCHES & APPROVALS 372
TABLE 387 MASIMO CORPORATION: DEALS 372
10.1.14 OMRON CORPORATION 374
TABLE 388 OMRON CORPORATION: COMPANY OVERVIEW 374
FIGURE 55 OMRON CORPORATION: COMPANY SNAPSHOT (2022) 375
TABLE 389 OMRON CORPORATION: PRODUCTS OFFERED 375
TABLE 390 OMRON CORPORATION: PRODUCT LAUNCHES & APPROVALS 378
TABLE 391 OMRON CORPORATION: DEALS 378
10.1.15 ARCHIMED SAS (NATUS MEDICAL) 379
TABLE 392 ARCHIMED SAS (NATUS MEDICAL): BUSINESS OVERVIEW 379
TABLE 393 ARCHIMED SAS (NATUS MEDICAL): PRODUCTS OFFERED 380
TABLE 394 ARCHIMED SAS (NATUS MEDICAL): DEALS 381
10.1.16 COMPUMEDICS LIMITED 382
TABLE 395 COMPUMEDICS LIMITED: BUSINESS OVERVIEW 382
FIGURE 56 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2023) 382
TABLE 396 COMPUMEDICS LIMITED: PRODUCTS OFFERED 383
TABLE 397 COMPUMEDICS LIMITED: PRODUCT LAUNCHES & APPROVALS 384
TABLE 398 COMPUMEDICS LIMITED: DEALS 384
10.1.17 NONIN MEDICAL, INC. 385
TABLE 399 NONIN MEDICAL, INC.: BUSINESS OVERVIEW 385
TABLE 400 NONIN MEDICAL, INC.: PRODUCTS OFFERED 385
TABLE 401 NONIN MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS 386
10.2 OTHER PLAYERS 387
10.2.1 BIOTRONIK 387
10.2.2 SCHILLER AG 388
10.2.3 SENSEONICS 389
10.2.4 CARDIOMO 390
10.2.5 VITLS 390
10.2.6 NETEERA 391
10.2.7 QARDIO 392
10.2.8 VIVIFY HEALTH 393
10.2.9 IRHYTHM TECHNOLOGIES, INC. 394
10.2.10 OSYPKA MEDICAL 395
10.2.11 CARDINAL HEALTH 396
10.2.12 MERIT MEDICAL SYSTEMS 397
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
11 APPENDIX 398
11.1 DISCUSSION GUIDE 398
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 403
11.3 CUSTOMIZATION OPTIONS 405
11.4 RELATED REPORTS 405
11.5 AUTHOR DETAILS 407